Status:
NOT_YET_RECRUITING
Ketamine and Lidocaine Infusion in Refractory Chronic Migraine
Lead Sponsor:
Assiut University
Conditions:
Refractory Chronic Migraine
Eligibility:
All Genders
18-60 years
Phase:
EARLY_PHASE1
Brief Summary
Ketamine and lidocaine infusion for refractory chronic migraine: Comparative Study
Eligibility Criteria
Inclusion
- All participants must fulfill the following inclusion criteria
- medically stable outpatients with confirmed diagnosis of refractory chronic migraine according to American Headache society
- Are reliable and willing to make themselves available for the duration of the study and are willing to follow up.
- Men or women older than 18years of age.
- clear written informed consent from each participant in the trial.
- Adult patients with refractory migraine or refractory chronic migraine defined according to the American headache society
Exclusion
- Pregnancy, active psychosis, liver disease, uncontrolled cardiac disease or cardiac rhythm abnormalities
- presence of clinically significant medical or psychiatric condition that may increase the risk associated with the study
- participation in any other type of medical research that may interfere with the interpretation of the study.
- patients with hemocoagulation disorders, local infection or those who refused to consent
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06935552
Start Date
June 1 2025
End Date
December 1 2026
Last Update
April 20 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.